⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKTX News
Akari Therapeutics plc ADR (0.01 USD)
Form 8-K
sec.gov
AKTX
Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones
globenewswire.com
AKTX
Form 8-K
sec.gov
AKTX
Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari’s Differentiated PH1 Payload Platform Following ASCO 2026
globenewswire.com
AKTX
Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance
globenewswire.com
AKTX
Form 8-K
sec.gov
AKTX
This Emerging Biotech Wave Could Create the Next Monster Healthcare Winners
globenewswire.com
AKTX
NTHI
MTVA
HCWB
Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models
globenewswire.com
AKTX
Akari Therapeutics Announces $5.5 Million Private Placement Offering
globenewswire.com
AKTX
Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase
globenewswire.com
AKTX